Moderator: Kevin Outterson, Executive Director, CARB-X, Professor of Law, Boston University

Panel:

• Lars Rebien Sorensen, Chairman of the Novo Nordisk Foundation and Novo Holdings
• Jeremy Farrar, Director, Wellcome Trust
• Dr. Malin Grape, Head of Antibiotics Unit, The Public Health Agency of Sweden
• Thomas Cueni, Director General, IFPMA
• Jayasree K. Iyer, Executive Director, Access to Medicine Foundation
• Francesca Colombo, Head of the Health Division, OECD

Antimicrobial resistance is one of the biggest threats to human health. The Novo Nordisk Foundation is hosting a session at the World Economic Forum’s Annual Meeting in Davos urging governments, the biopharma industry and other stakeholders to step up the urgency and respond to the crisis in #antimicrobialresistance with new funding models.

To watch a recording of this panel, please click here.